Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fattizzo

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|December 19, 2022
Case report: Transfusion independence and abolition of extravascular hemolysis in a PNH patient treated with pegcetacoplanBruno Fattizzo, Francesco Versino, Anna Zaninoni, et al.
Frontiers in Physiology|August 29, 2022
Effect of primary lesions in cytoskeleton proteins on red cell membrane stability in patients with hereditary spherocytosisCristina Vercellati, Anna Paola Marcello, Bruno Fattizzo, et al.
Journal of Internal Medicine|November 28, 2023
Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunizationFrancesco Versino, Nicoletta Revelli, Stefania Villa, et al.
Frontiers in Immunology|April 15, 2026
Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimabAntonella Sau, Daniela Onofrillo, Anna Caterina Russo, et al.
Frontiers in Oncology|October 15, 2021
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the LiteratureMarco Capecchi, Fabio Serpenti, Juri Giannotta, et al.
Scientific Reports|September 19, 2024
Natural history of chronic idiopathic neutropenia of the adultBruno Fattizzo, Alessandro Bosi, Michele Sorrenti, et al.
Seminars in Hematology|December 4, 2018
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid LeukemiaGianluigi Reda, Marta Riva, Bruno Fattizzo, et al.
Hematological Oncology|July 13, 2016
Biological and molecular characterization of a rare case of cutaneous Richter syndromeGianluigi Reda, Ramona Cassin, Sonia Fabris, et al.
British Journal of Haematology|March 12, 2022
Changing trends of splenectomy in hereditary spherocytosis: The experience of a reference Centre in the last 40 yearsCristina Vercellati, Anna Zaninoni, Anna P Marcello, et al.
European Journal of Haematology|September 17, 2013
Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemiaWilma Barcellini, Francesco Zaja, Anna Zaninoni, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|December 19, 2022
Case report: Transfusion independence and abolition of extravascular hemolysis in a PNH patient treated with pegcetacoplanBruno Fattizzo, Francesco Versino, Anna Zaninoni, et al.
Frontiers in Physiology|August 29, 2022
Effect of primary lesions in cytoskeleton proteins on red cell membrane stability in patients with hereditary spherocytosisCristina Vercellati, Anna Paola Marcello, Bruno Fattizzo, et al.
Journal of Internal Medicine|November 28, 2023
Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunizationFrancesco Versino, Nicoletta Revelli, Stefania Villa, et al.
Frontiers in Immunology|April 15, 2026
Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimabAntonella Sau, Daniela Onofrillo, Anna Caterina Russo, et al.
Frontiers in Oncology|October 15, 2021
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the LiteratureMarco Capecchi, Fabio Serpenti, Juri Giannotta, et al.
Scientific Reports|September 19, 2024
Natural history of chronic idiopathic neutropenia of the adultBruno Fattizzo, Alessandro Bosi, Michele Sorrenti, et al.
Seminars in Hematology|December 4, 2018
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid LeukemiaGianluigi Reda, Marta Riva, Bruno Fattizzo, et al.
Hematological Oncology|July 13, 2016
Biological and molecular characterization of a rare case of cutaneous Richter syndromeGianluigi Reda, Ramona Cassin, Sonia Fabris, et al.
British Journal of Haematology|March 12, 2022
Changing trends of splenectomy in hereditary spherocytosis: The experience of a reference Centre in the last 40 yearsCristina Vercellati, Anna Zaninoni, Anna P Marcello, et al.
European Journal of Haematology|September 17, 2013
Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemiaWilma Barcellini, Francesco Zaja, Anna Zaninoni, et al.
Pageof 14